Abstract
Problem 1) Maximum unknown, baseline increased, drug effects overadditively enhanced: the examination of dose response curves of functional synergism at different maxima reveals that, thereby, the combined effects (EA + b) never exceed the algebraic sum of the individual effects of A and B (EA + EB). Also, ED50 values will not be affected. Hence, larger combined effects and/or a decrease in ED50 indicates sequential potentiation (Pöch and Holzmann: J. Pharmacol. Meth. 4, 179, 1980) as observed, e. g., with isoprena-line in the presence of GTP on bovine coronary adenylate cyclase.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Consortia
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Deutsche Pharmakologische Gesellschaft. (1981). Deutsche Pharmakologische Gesellschaft. In: Deutsche Pharmakologische Gesellschaft. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-39536-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-39536-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-38668-2
Online ISBN: 978-3-662-39536-3
eBook Packages: Springer Book Archive